4:50 PM
 | 
Feb 24, 2010
 |  BC Extra  |  Company News

Shire withdraws Replagal BLA

Shire plc (LSE:SHP; NASDAQ:SHPGY) withdrew a BLA for Replagal agalsidase alfa to treat Fabry's disease. Shire, which submitted the BLA in December, made...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >